医学
白癜风
性病学
他克莫司
皮肤病科
钙调神经磷酸酶
皮密莫司
皮质类固醇
曲安奈德
外科
移植
作者
Priyamvada Roy,Subhranil Saha,P C Paul,A K Reza,A K Nandi,Sharmeen Sultana,Sib Shankar Saha,SMQ Akhter,S Khatun,M Habibunnahar
出处
期刊:PubMed
日期:2016-10-01
卷期号:25 (4): 620-627
被引量:6
摘要
Vitiligo is an acquired pigmentary skin disorder which is disfiguring and difficult to treat. Cure and response rates for vitiligo are significantly lower. This study was conducted to evaluate the effectiveness of topical corticosteroid, topical calcineurin inhibitors (tacrolimus) and combination of them in the treatment of vitilligo in two tertiary care Hospital, in the Department of Dermatology and Venereology OPD (out patient department) in Mymensingh Medical College Hospital and Jahurul Islam Medical College Hospital, Bajitpur, Kishoregonj from January 2015 to December 2015. Newly diagnosed 112 vitiligo patients, aged more than 1 year to 70 years were assigned for therapy and to observe the response. This study indicates that, in case of vitiligo treatment topical tacrolimus was the most effective drug. Topical tacrolimus, topical corticosteroid and combination of them are to be effective in the treatment of vitiligo with reduction in the number of vitiliginous spots by increased repigmentation. But topical tacrolimus was the most effective drug, as it caused highest percentage of repigmentation of vitiliginous spot.
科研通智能强力驱动
Strongly Powered by AbleSci AI